Bristol-Myers Squibb Co. (BMY) | Common-Size Income Statement
See also
- Johnson & Johnson (JNJ), Common-Size Income Statement
- Pfizer Inc. (PFE), Common-Size Income Statement
- Novartis AG (NVS), Common-Size Income Statement
- Merck & Co. Inc. (MRK), Common-Size Income Statement
- GlaxoSmithKline PLC (GSK), Common-Size Income Statement
- Abbott Laboratories (ABT), Common-Size Income Statement
- Sanofi (SNY), Common-Size Income Statement
- Novo Nordisk A/S (NVO), Common-Size Income Statement
- UnitedHealth Group Inc. (UNH), Common-Size Income Statement
- AstraZeneca PLC (AZN), Common-Size Income Statement
- Eli Lilly & Co. (LLY), Common-Size Income Statement
- Medtronic Inc. (MDT), Common-Size Income Statement
- Baxter International Inc. (BAX), Common-Size Income Statement
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Bristol-Myers Squibb Co., Common-Size Consolidated Income Statement
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Net sales | |
|
|
|
|
|
Cost of products sold | |
|
|
|
|
|
Gross profit | % |
% |
% |
% |
% |
|
Marketing, selling and administrative | |
|
|
|
|
|
Advertising and product promotion | |
|
|
|
|
|
Research and development | |
|
|
|
|
|
Acquired in-process research and development | |
|
|
|
|
|
Provision for restructuring | |
|
|
|
|
|
Litigation expense, net | |
|
|
|
|
|
Operating income | % |
% |
% |
% |
% |
|
Equity in net income of affiliates | |
|
|
|
|
|
Gain on sale of ImClone shares | |
|
|
|
|
|
Interest expense | |
|
|
|
|
|
Interest income | |
|
|
|
|
|
Impairment and loss on sale of manufacturing operations | |
|
|
|
|
|
Gain on sale of product lines, businesses and assets | |
|
|
|
|
|
Other income received from alliance partners | |
|
|
|
|
|
Pension curtailment and settlement charges | |
|
|
|
|
|
Litigation (charges) recoveries | |
|
|
|
|
|
Product liability (charges) recoveries | |
|
|
|
|
|
Other | |
|
|
|
|
|
Other income (expense) | % |
% |
% |
% |
% |
|
Earnings from continuing operations before income taxes | % |
% |
% |
% |
% |
|
Provision for income taxes | |
|
|
|
|
|
Net earnings from continuing operations | % |
% |
% |
% |
% |
|
Net earnings from discontinued operations | |
|
|
|
|
|
Net earnings | % |
% |
% |
% |
% |
|
Net earnings attributable to noncontrolling interest | |
|
|
|
|
|
Net earnings attributable to Bristol-Myers Squibb Company | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center